 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Audentes Therapeutics Inc. (BOLD)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-11-08 Sale | 2019-11-12 5:32 pm | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 14,426 | $30 | $432,780 | 171,814 (Indirect Direct) | View |
| 2019-09-23 Sale | 2019-09-25 6:11 pm | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 11,000 | $32.16 | $353,798 | 276,044 (Indirect Direct) | View |
| 2019-08-12 Sale | 2019-08-14 7:03 pm | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 20,000 | $34.04 | $680,835 | 171,814 (Indirect Direct) | View |
| 2019-06-24 Sale | 2019-06-26 4:07 pm | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 21,000 | $37.79 | $793,614 | 290,001 (Indirect Direct) | View |
| 2019-05-13 Sale | 2019-05-15 4:42 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $36.98 | $369,798 | 30,870 (Direct) | View |
| 2019-03-25 Sale | 2019-03-27 5:03 pm | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 21,558 | $36 | $776,073 | 306,099 (Indirect Direct) | View |
| 2019-02-25 Sale | 2019-02-27 4:32 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $30.06 | $300,553 | 40,870 (Direct) | View |
| 2019-02-25 Sale | 2019-02-27 4:31 pm | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 21,000 | $30 | $630,000 | 171,814 (Indirect Direct) | View |
| 2018-12-24 Sale | 2018-12-27 5:43 pm | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 32,000 | $18.62 | $595,799 | 325,799 (Indirect Direct) | View |
| 2018-11-15 Sale | 2018-11-16 6:34 pm | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 24,000 | $22.49 | $539,760 | 345,799 (Indirect Direct) | View |
| 2018-10-01 Sale | 2018-10-02 7:05 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $36.88 | $368,788 | 50,870 (Direct) | View |
| 2018-10-01 Sale | 2018-10-02 7:04 pm | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 21,000 | $38.16 | $801,372 | 171,814 (Indirect Direct) | View |
| 2018-09-28 Sale | 2018-10-02 7:03 pm | Audentes Therapeutics Inc. | BOLD | GRAY JOHN T. SVP Chief Scientific Officer | 87 | $40 | $3,480 | 71,669 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-12-05 Tax Withholding | 2019-12-09 5:17 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 505 | $59.21 | 21,314 (Direct) | View |
| 2019-12-05 Tax Withholding | 2019-12-09 5:16 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 1,974 | $59.21 | 171,814 (Direct) | View |
| 2019-12-05 Tax Withholding | 2019-12-09 5:15 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 505 | $59.21 | 54,704 (Direct) | View |
| 2019-11-08 Exercise | 2019-11-12 5:32 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 14,426 | $9.5 | 171,814 (Direct) | View |
| 2019-11-08 Exercise | 2019-11-12 5:32 pm | N/A 2025-12-18 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 14,426 | $9.5 | 171,814 (Direct) | View |
| 2019-09-05 Tax Withholding | 2019-09-09 4:06 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 505 | $31.02 | 21,819 (Direct) | View |
| 2019-09-05 Tax Withholding | 2019-09-09 4:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 1,974 | $31.02 | 171,814 (Direct) | View |
| 2019-09-05 Tax Withholding | 2019-09-09 4:04 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 505 | $31.02 | 55,209 (Direct) | View |
| 2019-08-12 Exercise | 2019-08-14 7:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 20,000 | $9.5 | 171,814 (Direct) | View |
| 2019-08-12 Exercise | 2019-08-14 7:03 pm | N/A 2025-12-18 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 20,000 | $9.5 | 171,814 (Direct) | View |
| 2019-07-15 Option Award | 2019-07-17 4:26 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Conner Edward R. SVP Chief Medical Officer | 30,000 | $0 | 90,000 (Direct) | View |
| 2019-07-15 Option Award | 2019-07-17 4:26 pm | N/A 2029-07-15 | Audentes Therapeutics Inc. | BOLD | Conner Edward R. SVP Chief Medical Officer | 90,000 | $36.08 | 90,000 (Direct) | View |
| 2019-06-05 Tax Withholding | 2019-06-07 4:42 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 757 | $37.31 | 17,479 (Direct) | View |
| 2019-06-05 Tax Withholding | 2019-06-07 4:41 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 3,332 | $37.31 | 171,814 (Direct) | View |
| 2019-06-05 Tax Withholding | 2019-06-07 4:41 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 1,009 | $37.31 | 55,714 (Direct) | View |
| 2019-06-05 Tax Withholding | 2019-06-07 4:40 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 1,009 | $37.31 | 22,324 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-15 4:42 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 30,870 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-15 4:42 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 30,870 (Direct) | View |
| 2019-03-28 Option Award | 2019-04-01 5:54 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Meltz Mark A VP | 37,333 | $0 | 104,000 (Direct) | View |
| 2019-03-28 Option Award | 2019-04-01 5:54 pm | N/A 2029-03-28 | Audentes Therapeutics Inc. | BOLD | Meltz Mark A VP | 104,000 | $37.26 | 104,000 (Direct) | View |
| 2019-02-25 Exercise | 2019-02-27 4:32 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 40,870 (Direct) | View |
| 2019-02-25 Exercise | 2019-02-27 4:32 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 40,870 (Direct) | View |
| 2019-02-25 Exercise | 2019-02-27 4:31 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 17,000 | $0.78 | 171,814 (Direct) | View |
| 2019-02-25 Exercise | 2019-02-27 4:31 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 4,000 | $2.19 | 171,814 (Direct) | View |
| 2019-02-25 Exercise | 2019-02-27 4:31 pm | N/A 2023-09-25 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 17,000 | $0.78 | 171,814 (Direct) | View |
| 2019-02-25 Exercise | 2019-02-27 4:31 pm | N/A 2025-02-04 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 4,000 | $2.19 | 171,814 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:50 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 63,700 | $0 | 177,450 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:50 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 177,450 | $24.74 | 177,450 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:29 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 23,333 | $0 | 65,000 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:29 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 65,000 | $24.74 | 65,000 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:28 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Smith Julie Director | 16,200 | $24.74 | 16,200 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:27 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Schuetz Thomas J. Director | 16,200 | $24.74 | 16,200 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:25 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 17,500 | $0 | 48,750 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:25 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 48,750 | $24.74 | 48,750 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:23 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Morrison Scott W Director | 16,200 | $24.74 | 16,200 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:22 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 16,200 | $24.74 | 16,200 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:21 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Jarrett Jennifer Director | 16,200 | $24.74 | 16,200 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:20 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 23,333 | $0 | 65,000 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:20 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 65,000 | $24.74 | 65,000 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:20 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Goldberg Mark Alan Director | 16,200 | $24.74 | 16,200 (Direct) | View |
| 2019-01-24 Exercise | 2019-01-25 7:28 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 8,300 | $2.765 | 156,429 (Direct) | View |
| 2019-01-24 Exercise | 2019-01-25 7:28 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 8,300 | $2.765 | 156,429 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-04 4:48 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Mosbrooker Eric SVP Chief Commercial Officer | 31,500 | $0 | 87,750 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-04 4:48 pm | N/A 2029-01-03 | Audentes Therapeutics Inc. | BOLD | Mosbrooker Eric SVP Chief Commercial Officer | 87,750 | $22.01 | 87,750 (Direct) | View |
| 2018-12-06 Exercise | 2018-12-10 4:39 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 40,000 | $0.78 | 171,814 (Direct) | View |
| 2018-12-06 Exercise | 2018-12-10 4:39 pm | N/A 2023-09-25 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 40,000 | $0.78 | 171,814 (Direct) | View |
| 2018-11-15 Option Award | 2018-11-16 6:41 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | NEWMAN MARY VP | 660 | $19.64 | 660 (Direct) | View |
| 2018-11-15 Option Award | 2018-11-16 6:37 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 736 | $19.64 | 736 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 100 | $0.79 | 50,870 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 1,101 | $0.79 | 50,870 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 3,900 | $0.79 | 50,870 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 200 | $0.79 | 50,870 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 4,699 | $0.79 | 50,870 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:05 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 50,870 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:04 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 2,144 | $0.78 | 171,814 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:04 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 5,330 | $0.78 | 171,814 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:04 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 5,448 | $0.78 | 171,814 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:04 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 8,078 | $0.78 | 171,814 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:04 pm | N/A 2023-09-25 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 21,000 | $0.78 | 171,814 (Direct) | View |
| 2018-09-28 Exercise | 2018-10-02 7:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | GRAY JOHN T. SVP Chief Scientific Officer | 87 | $1.05 | 71,669 (Direct) | View |
| 2018-09-28 Exercise | 2018-10-02 7:03 pm | N/A 2024-09-17 | Audentes Therapeutics Inc. | BOLD | GRAY JOHN T. SVP Chief Scientific Officer | 87 | $1.05 | 71,669 (Direct) | View |